Aspen Aerogels, Inc. (NYSE:ASPN) Receives $5.19 Consensus Price Target from Analysts

Aspen Aerogels, Inc. (NYSE:ASPN) has been assigned an average recommendation of “Hold” from the six analysts that are presently covering the stock, MarketBeat.com reports. Two investment analysts have rated the stock with a sell rating, one has given a hold rating and three have assigned a buy rating to the company. The average 12-month price target among analysts that have updated their coverage on the stock in the last year is $5.1875.

A number of brokerages have recently commented on ASPN. Barclays increased their price target on Aspen Aerogels from $3.00 to $4.00 and gave the company an “underweight” rating in a research note on Monday, May 11th. Roth Capital reaffirmed a “buy” rating and issued a $5.75 target price on shares of Aspen Aerogels in a report on Friday, May 8th. Wall Street Zen raised Aspen Aerogels from a “sell” rating to a “hold” rating in a report on Saturday, May 16th. Finally, Weiss Ratings reiterated a “sell (d-)” rating on shares of Aspen Aerogels in a research report on Wednesday, June 24th.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently made changes to their positions in the company. Invesco Ltd. boosted its position in Aspen Aerogels by 237.9% during the 4th quarter. Invesco Ltd. now owns 4,129,934 shares of the construction company’s stock worth $11,688,000 after buying an additional 2,907,558 shares during the period. Needham Investment Management LLC increased its position in Aspen Aerogels by 26.5% in the 4th quarter. Needham Investment Management LLC now owns 4,351,700 shares of the construction company’s stock valued at $12,315,000 after acquiring an additional 912,000 shares during the period. JPMorgan Chase & Co. increased its position in Aspen Aerogels by 105.4% in the 2nd quarter. JPMorgan Chase & Co. now owns 1,246,506 shares of the construction company’s stock valued at $7,379,000 after acquiring an additional 639,753 shares during the period. Goldman Sachs Group Inc. raised its stake in shares of Aspen Aerogels by 89.7% during the first quarter. Goldman Sachs Group Inc. now owns 1,274,356 shares of the construction company’s stock valued at $8,143,000 after acquiring an additional 602,586 shares during the last quarter. Finally, State Street Corp raised its stake in shares of Aspen Aerogels by 28.6% during the fourth quarter. State Street Corp now owns 2,501,469 shares of the construction company’s stock valued at $7,079,000 after acquiring an additional 556,833 shares during the last quarter. Institutional investors and hedge funds own 97.64% of the company’s stock.

Aspen Aerogels Trading Down 0.1%

Shares of Aspen Aerogels stock opened at $4.67 on Friday. The firm has a market capitalization of $386.64 million, a PE ratio of -3.43 and a beta of 2.98. The company has a current ratio of 2.89, a quick ratio of 2.54 and a debt-to-equity ratio of 0.32. The firm’s 50 day moving average is $5.66 and its 200 day moving average is $4.32. Aspen Aerogels has a 1 year low of $2.30 and a 1 year high of $9.78.

Aspen Aerogels (NYSE:ASPN) last issued its quarterly earnings data on Thursday, May 7th. The construction company reported ($0.28) EPS for the quarter, missing the consensus estimate of ($0.27) by ($0.01). Aspen Aerogels had a negative net margin of 48.64% and a negative return on equity of 22.16%. The company had revenue of $37.88 million during the quarter, compared to the consensus estimate of $36.58 million. During the same period in the previous year, the company earned ($0.06) EPS. Aspen Aerogels’s revenue for the quarter was down 51.8% on a year-over-year basis. Aspen Aerogels has set its Q2 2026 guidance at -0.240–0.17 EPS. Equities research analysts forecast that Aspen Aerogels will post -0.8 earnings per share for the current fiscal year.

About Aspen Aerogels

Aspen Aerogels, Inc, headquartered in Northborough, Massachusetts, develops and manufactures high-performance aerogel insulation materials and custom engineered solutions. Founded in 2001 as a spin-out from Department of Energy research, the company pursued an initial public offering on the NYSE in 2014 under the ticker ASPN. Aspen Aerogels combines proprietary aerogel formulations with advanced manufacturing processes to deliver products known for their low thermal conductivity, lightweight construction and robust mechanical properties.

The company’s product portfolio spans blanket insulation, boards, and custom shapes built around several proprietary brands, including Pyrogel, Cryogel and Spaceloft.